Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Ellipses Pharma Limited

Ellipses Launches Pioneering Clinical Trial Programme in Middle East
From Ellipses Pharma Limited
Via Business Wire
Ellipses Pharma Presents Preliminary Data From the First in Human Phase-1/2 Trial of EP0042, a Dual FLT-3 and Aurora Kinase Inhibitor, at ASH
From Ellipses Pharma Limited
Via Business Wire
Ellipses Pharma Presents Design of Newly Initiated Phase 1/2a Trial of Vosilasarm (EP0062) at SABCS
From Ellipses Pharma Limited
Via Business Wire
Ellipses Pharma to Present Clinical Updates at Leading U.S. Breast and Blood Cancer Conferences
From Ellipses Pharma Limited
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.